1. Consensus on the secondary prevention of primary liver cancer

   • Yuemin Nan
   • Xiaoyuan Xu
   • Chinese Society of Hepatology, Chinese Medical Association

   Consensus Open access 30 November 2021 Pages: 1289 - 1300

   

2. Are herbals more hepatotoxic than prescription medications?

   • Vincent L. Chen
   • Robert J. Fontana

   Editorial 05 October 2021 Pages: 1301 - 1304

3. Gut microbiota alteration in hepatobiliary diseases: cause-and-effect relationship

   • Xiaoyan Guo
   • Yanmei Jiao
   • Fu-Sheng Wang

   Editorial 15 November 2021 Pages: 1305 - 1308

   

4. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids

   • Gayatri Ramakrishna
   • Preedia E. Babu
   • Nirupma Trehanpati

   Review Article 01 October 2021 Pages: 1309 - 1317

   

5. Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis

   • Xiaoning Wu
   • Jia Hong
   • Jidong Jia

   Original Article 29 November 2021 Pages: 1318 - 1327

   

6. Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients

   • Hye Yeon Chon
   • Sang Hoon Ahn
   • Seung Up Kim

   Original Article 20 November 2021 Pages: 1328 - 1336

   

7. Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study

   • Hui-Hui Liu
   • Ye-Xuan Cao
   • Jian-Jun Li

   Original Article 09 October 2021 Pages: 1337 - 1346

   

8. Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease

   • Ji Won Yoon
   • Min Joo Kim
   • Min-Sun Kwak

   Original Article 04 October 2021 Pages: 1347 - 1355

   

9. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?

   • Shujie Dong
   • Huihong Qi
   • Rongsheng Zhao

   Original Article 06 September 2021 Pages: 1356 - 1375

   

10. ‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure

    • Ashok Choudhury
    • Rajan Vijayaraghavan
    • APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party

    Original Article 04 October 2021 Pages: 1376 - 1388

    

11. Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction

    • Nidhi Nautiyal
    • Deepanshu Maheshwari
    • Shiv Kumar Sarin

    Original Article 25 August 2021 Pages: 1389 - 1401

    

12. Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

    • Fanping Meng
    • Jinfang Zhao
    • Fu-Sheng Wang

    Original Article Open access 30 November 2021 Pages: 1402 - 1412

    

13. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis

    • Lun-Jie Yan
    • Sheng-Yu Yao
    • Tao Li

    Original Article 03 September 2021 Pages: 1413 - 1420

    

14. Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

    • Wei Teng
    • Ting-Tsung Chang
    • Jaw-Ching Wu

    Original Article 06 November 2021 Pages: 1421 - 1430

    

15. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

    • Ming Shi
    • Yuan-Yuan Li
    • Fu-Sheng Wang

    Original Article Open access 29 November 2021 Pages: 1431 - 1441

    

16. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery

    • Burak Özbaş
    • Onur Keskin
    • Cihan Yurdaydin

    Original Article 03 June 2021 Pages: 1442 - 1455

    

17. Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

    • Yi-Shin Huang
    • Ting-Tsung Chang
    • Yi-Hsiang Huang

    Original Article 11 August 2021 Pages: 1456 - 1465

    

18. Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients

    • Huei-Ru Cheng
    • Hung-Chih Yang
    • Jia-Horng Kao

    Correction 25 September 2021 Pages: 1466 - 1467